Biohaven Ltd

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$13.62

-0.27 (-1.94%)

As of Sep 20, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 78%

Hold 4 17%

Sell 1 4%

Price Target

Analyst Price Target +120.7% upside

Low Target $17.22

Average Target $30.06

High Target $35.82

Current Price $13.62

Current
$13.62

Target
$30.06

$17.22 $30.06 avg $35.82

Scenario Analysis

Bear Case

$17.22

26.4%

Low target

Base Case

$30.06

+120.7%

Avg target

Bull Case

$35.82

+163.0%

High target

Risk/Reward

6.2x

Highly favorable

Price in Context

52-Week High

$18.57

-26.6% from high

52-Week Low

$7.48

+82.1% from low

Target vs 52W High

$30.06

+61.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%